AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 10
- Registration Number
- NCT00689247
- Locations
- 🇬🇧
Research Site, Macclesfield, Cheshire, United Kingdom
Single Ascending Dose Study (SAD) iv Formulation
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT00688831
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2010-10-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 158
- Registration Number
- NCT00689325
- Locations
- 🇳🇱
Research Site, Zwolle, Netherlands
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
Completed
- Conditions
- Peripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2012-03-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 9000
- Registration Number
- NCT00689377
- Locations
- 🇨🇭
Research Site, Zurich, Switzerland
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 112
- Registration Number
- NCT00687141
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2008-06-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT00687245
Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Behavioral: Educational intervention
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 160
- Registration Number
- NCT00687310
Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 8000
- Registration Number
- NCT00687492
- Locations
- 🇻🇳
Research Site, Hcmc, Vietnam
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00687232
- Locations
- 🇯🇵
Research Site, Osaka-city, Osaka, Japan
Phase IIA Study in Patients With Schizophrenia
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 106
- Registration Number
- NCT00686998
- Locations
- 🇺🇸
Research Site, Rockville, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath